Clinical Trial Update: Efficacy and Safety Study Comparing CPL409116 to Placebo in Participants With Active Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the efficacy and safety of CPL409116 versus placebo in adults with active rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• CPL409116

Snippet

Sponsor: Celon Pharma SA | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED